Essential role of phosphoinositide 3‐kinase gamma in eosinophil chemotaxis within acute pulmonary inflammation
暂无分享,去创建一个
P. Finan | J. Westwick | E. Hirsch | M. Wymann | C. Walker | A. Trifilieff | E. Sawicka | M. Edwards | Nicholas Duggan | Matthew J. Thomas | C. Owen
[1] T. Kadowaki,et al. PI3K is a negative regulator of IgE production. , 2008, International immunology.
[2] K. Okkenhaug,et al. Role of the phosphoinositide 3‐kinase p110δ in generation of type 2 cytokine responses and allergic airway inflammation , 2007, European journal of immunology.
[3] So Ri Kim,et al. Phosphoinositide 3-kinase-δ inhibitor reduces vascular permeability in a murine model of asthma , 2006 .
[4] S. Kelsen,et al. CXCR3 chemokine receptor-induced chemotaxis in human airway epithelial cells: role of p38 MAPK and PI3K signaling pathways. , 2006, American journal of physiology. Cell physiology.
[5] R. Parry,et al. Evidence that phospholipase C‐dependent, calcium‐independent mechanisms are required for directional migration of T lymphocytes in response to the CCR4 ligands CCL17 and CCL22 , 2006, Journal of leukocyte biology.
[6] Yong Chul Lee,et al. Inhibition of phosphoinositide 3‐kinase δ attenuates allergic airway inflammation and hyperresponsiveness in murine asthma model , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] E. Vigorito,et al. Cutting Edge: T Cell Development Requires the Combined Activities of the p110γ and p110δ Catalytic Isoforms of Phosphatidylinositol 3-Kinase1 , 2005, The Journal of Immunology.
[8] R. Djukanović,et al. Differential dependence of eosinophil chemotactic responses on phosphoinositide 3‐kinase (PI3K) , 2005, Allergy.
[9] M. Teixeira,et al. Phosphoinositide‐3 kinases critically regulate the recruitment and survival of eosinophils in vivo: importance for the resolution of allergic inflammation , 2005, Journal of leukocyte biology.
[10] William W. Busse,et al. Allergy and asthma. , 2005, The Journal of allergy and clinical immunology.
[11] P. Finan,et al. Airway inflammation: chemokine‐induced neutrophilia and the class I phosphoinositide 3‐kinases , 2005, European journal of immunology.
[12] C. Vlahos,et al. An anti-inflammatory role for a phosphoinositide 3-kinase inhibitor LY294002 in a mouse asthma model. , 2005, International immunopharmacology.
[13] M. Humbert,et al. New chemokine targets for asthma therapy , 2005, Current allergy and asthma reports.
[14] S. Ward. Faculty Opinions recommendation of Phosphatidylinositol 3-kinase regulates thymic exit. , 2005 .
[15] S. Phipps,et al. Eosinophils in repair and remodelling , 2004 .
[16] S. Cassel,et al. Understanding asthma pathogenesis: linking innate and adaptive immunity , 2004, Current opinion in pediatrics.
[17] Y. Hamasaki,et al. Regulatory mechanisms of Th2 cytokine-induced eotaxin-3 production in bronchial epithelial cells: possible role of interleukin 4 receptor and nuclear factor-kappaB. , 2004, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[18] P. Barnes. New drugs for asthma , 2004, Nature Reviews Drug Discovery.
[19] C. Martínez-A,et al. Differential requirements for DOCK2 and phosphoinositide-3-kinase gamma during T and B lymphocyte homing. , 2004, Immunity.
[20] Huanzhong Shi. Eosinophils function as antigen‐presenting cells , 2004, Journal of leukocyte biology.
[21] K. Okkenhaug,et al. Cutting Edge: Differential Roles for Phosphoinositide 3-Kinases, p110γ and p110δ, in Lymphocyte Chemotaxis and Homing1 , 2004, The Journal of Immunology.
[22] N. Lukacs,et al. Respiratory syncytial virus-induced chemokine production: linking viral replication to chemokine production in vitro and in vivo. , 2004, The Journal of infectious diseases.
[23] S. Ward. Do phosphoinositide 3-kinases direct lymphocyte navigation? , 2004, Trends in immunology.
[24] H-Z Shi,et al. Endobronchial eosinophils preferentially stimulate T helper cell type 2 responses , 2003, Allergy.
[25] D. Staunton,et al. Selective role of PI3Kδ in neutrophil inflammatory responses , 2003 .
[26] P. Finan,et al. Isoform-specific phosphoinositide 3-kinase inhibitors as therapeutic agents. , 2003, Current opinion in pharmacology (Print).
[27] D. Postma,et al. Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study. , 2003, American journal of respiratory and critical care medicine.
[28] James J. Lee,et al. A Causative Relationship Exists Between Eosinophils and the Development of Allergic Pulmonary Pathologies in the Mouse1 , 2003, The Journal of Immunology.
[29] D. Staunton,et al. Essential Role of Phosphoinositide 3-Kinase δ in Neutrophil Directional Movement , 2003, The Journal of Immunology.
[30] K. Okkenhaug,et al. Impaired B and T Cell Antigen Receptor Signaling in p110δ PI 3-Kinase Mutant Mice , 2002, Science.
[31] C. Bizer,et al. Eosinophils Express Functional IL-13 in Eosinophilic Inflammatory Diseases1 , 2002, The Journal of Immunology.
[32] Marc W. Kirschner,et al. A PtdInsP3- and Rho GTPase-mediated positive feedback loop regulates neutrophil polarity , 2002, Nature Cell Biology.
[33] Paul Herzmark,et al. Lipid products of PI(3)Ks maintain persistent cell polarity and directed motility in neutrophils , 2002, Nature Cell Biology.
[34] Ion Gresser,et al. Type I interferons produced by dendritic cells promote their phenotypic and functional activation. , 2002, Blood.
[35] Dianqing Wu,et al. Neutrophils lacking phosphoinositide 3-kinase γ show loss of directionality during N-formyl-Met-Leu-Phe-induced chemotaxis , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[36] P. Finan,et al. Phosphoinositide 3-Kinase γ Is an Essential Amplifier of Mast Cell Function , 2002 .
[37] R. Shenkar,et al. Involvement of Phosphoinositide 3-Kinases in Neutrophil Activation and the Development of Acute Lung Injury1 , 2001, The Journal of Immunology.
[38] Q. Hamid,et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. , 2001, The Journal of allergy and clinical immunology.
[39] N. Aoike,et al. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. , 2001, The Journal of allergy and clinical immunology.
[40] A. McKenzie,et al. Elemental signals regulating eosinophil accumulation in the lung , 2001, Immunological reviews.
[41] G. Walsh. Eosinophil granule proteins and their role in disease , 2001, Current opinion in hematology.
[42] K. Chung,et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response , 2000, The Lancet.
[43] A. Mantovani,et al. Lipids on the move: phosphoinositide 3-kinases in leukocyte function. , 2000, Immunology today.
[44] W L Stanford,et al. Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. , 2000, Science.
[45] Dianqing Wu,et al. Roles of PLC-β2 and -β3 and PI3Kγ in Chemoattractant-Mediated Signal Transduction , 2000 .
[46] Silvano Sozzani,et al. Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation , 2000 .
[47] S. Weiland,et al. Prevalence of respiratory and atopic disorders among children in the East and West of Germany five years after unification. , 1999, The European respiratory journal.
[48] Choon-Sik Park,et al. Interleukin (IL)-5 downregulates tumor necrosis factor (TNF)-induced eotaxin messenger RNA (mRNA) expression in eosinophils. Induction of eotaxin mRNA by TNF and IL-5 in eosinophils. , 1999, American journal of respiratory cell and molecular biology.
[49] Lewis C. Cantley,et al. The Role of Phosphoinositide 3-Kinase Lipid Products in Cell Function* , 1999, The Journal of Biological Chemistry.
[50] P. Foster,et al. Cellular and molecular regulation of eosinophil trafficking to the lung , 1998, Immunology and cell biology.
[51] C. Macarthur,et al. Effectiveness of prophylactic inhaled steroids in childhood asthma: a systemic review of the literature. , 1997, The Journal of allergy and clinical immunology.
[52] H. Kita,et al. Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9. , 1997, American journal of respiratory cell and molecular biology.
[53] P. Hawkins,et al. The Gβγ Sensitivity of a PI3K Is Dependent upon a Tightly Associated Adaptor, p101 , 1997, Cell.
[54] B. Hemmings. UPDATE: PH Domains--A Universal Membrane Adapter , 1997, Science.
[55] H. Kita,et al. Constitutive production of IL-4 and IL-10 and stimulated production of IL-8 by normal peripheral blood eosinophils. , 1996, Journal of immunology.
[56] P. Leder,et al. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia , 1996, Nature Medicine.
[57] S. Volinia,et al. Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase. , 1995, Science.
[58] F. Levi-Schaffer,et al. Cytokine generation by eosinophils. , 1994, The Journal of allergy and clinical immunology.
[59] J. Tavernier,et al. Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion , 1994, The Journal of experimental medicine.
[60] M. Wjst,et al. Road traffic and adverse effects on respiratory health in children. , 1993, BMJ.
[61] D. Wong,et al. Human eosinophils can express the cytokines tumor necrosis factor-alpha and macrophage inflammatory protein-1 alpha. , 1993, The Journal of clinical investigation.
[62] R. Todd,et al. Human eosinophils express transforming growth factor alpha , 1990, The Journal of experimental medicine.
[63] Bernd Giese,et al. Targeting phosphoinositide 3-kinase: moving towards therapy. , 2008, Biochimica et biophysica acta.
[64] So Ri Kim,et al. Phosphoinositide 3-kinase-delta inhibitor reduces vascular permeability in a murine model of asthma. , 2006, The Journal of allergy and clinical immunology.
[65] K. Okkenhaug,et al. Cutting edge: differential roles for phosphoinositide 3-kinases, p110gamma and p110delta, in lymphocyte chemotaxis and homing. , 2004, Journal of immunology.
[66] P. Cullen,et al. Membrane targeting by pleckstrin homology domains. , 2004, Current topics in microbiology and immunology.
[67] D. Staunton,et al. Selective role of PI3K delta in neutrophil inflammatory responses. , 2003, Biochemical and biophysical research communications.
[68] P. Finan,et al. Phosphoinositide 3-kinase gamma is an essential amplifier of mast cell function. , 2002, Immunity.
[69] L. McHeyzer-Williams,et al. Development of antigen-specific helper T cell responses in vivo: antigen-specific Th cell subsets. , 2002, Advances in experimental medicine and biology.
[70] M. Waterfield,et al. Synthesis and function of 3-phosphorylated inositol lipids. , 2001, Annual review of biochemistry.
[71] Z. Li,et al. Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction. , 2000, Science.
[72] C. Garlanda,et al. Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. , 2000, Science.
[73] B. Hemmings. PH domains--a universal membrane adapter. , 1997, Science.
[74] P. Hawkins,et al. The G beta gamma sensitivity of a PI3K is dependent upon a tightly associated adaptor, p101. , 1997, Cell.
[75] F. Levi-Schaffer,et al. Identification of interleukin-2 in human peripheral blood eosinophils. , 1996, Immunology.
[76] E. Gelfand,et al. Murine animal models to study the central role of T cells in immediate-type hypersensitivity responses. , 1996, Advances in experimental medicine and biology.